Oxford Lane Capital's 8.25% Term Preferred Series 2031 is now trading below par with a yield to maturity of 9.04%, reflecting significant credit risk concerns. The company's net asset value (NAV) per share has fallen 50% year-over-year due to over-distribution and portfolio devaluation. This decline, along with dividend cuts and a reverse stock split, has caused the shares to trade at a discount, removing previous hedging benefits for fixed-income investors. Given these factors, the fixed-income products from Oxford Lane Capital, including OXLCM, are currently considered unattractive investments.
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Red Light Holland, after acquiring Filament Health, has expanded its capabilities in pharmaceutical-grade psilocybin development. Filament completed a shipment of its botanical psilocybin drug candidate, PEX010, to the European Union to support multi...
